Thursday, June 23, 2022 9:00:45 AM
From news release dated September 27, 2021 - "Cannabix devices are in the advanced prototype and pre-clinical testing stage."
From the Global Center for Medical Innovation (GCMI):
Medical device innovation does not come easy, or cheap. Nor should it. The stakes at every level are about as high as they come in innovation of any kind. From Concept to Cure, the seven stages of the medical device development collectively consume as many as seven years or more, tens of millions of dollars or more and no assurance of making it to market. Trust at every stage is critical.
The Seven Stages of Medical Device Development
Research and Development
Preclinical Testing
Permission for Clinical Trial (510(k), IDE – Investigational Device Exemption, PMA – Premarket Notification Application)
Clinical Trials
Manufacturing
Permission to Market
Post Market Requirements
Full Stop
The above information puts into perspective a reasonable expectation of a timeline for Cannabix moving forward. Cannabix is working on what is for all practical purposes a medical device. Which is why they use the terminology - pre-clinical. I wouldn't expect there to be a leapfrog to commercialization/monetization anytime in the near future.
Have @ It
M$
Recent BLOZF News
- Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • InvestorsHub NewsWire • 04/30/2024 12:53:40 PM
- Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • InvestorsHub NewsWire • 04/25/2024 12:52:01 PM
- Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • InvestorsHub NewsWire • 04/22/2024 12:49:29 PM
- Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • InvestorsHub NewsWire • 04/16/2024 12:52:49 PM
- Cannabix Quantifies Marijuana Breath Samples from Maryland Green Lab - Results Analyzed at North Louisiana Criminalistics Laboratory • InvestorsHub NewsWire • 01/18/2024 02:56:11 PM
- Shares Up on Patent Filing for Marijuana Breathalyzer • AllPennyStocks.com • 01/03/2024 07:00:00 PM
- Cannabix Technologies Files Patent for Proprietary Laboratory Drug Analysis Device • InvestorsHub NewsWire • 01/03/2024 02:30:21 PM
- Cannabix Technologies to Participate in Green Lab Held by Montgomery County Police Department (Maryland) • InvestorsHub NewsWire • 12/22/2023 01:46:36 PM
- Cannabix Completes Initial Electronics Testing on Contactless Alcohol Breathalyzer, Commences International Certification Plans • InvestorsHub NewsWire • 11/07/2023 02:09:46 PM
- Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • InvestorsHub NewsWire • 10/03/2023 12:50:42 PM
- Cannabix Technologies Files Breath Sample Capture Patent and Detects Delta- 8 THC in Early Testing • InvestorsHub NewsWire • 08/04/2023 12:52:02 PM
- Cannabix's MSBS Marijuana Breathalyzer Technology Detects THC in Breath after Edibles Consumption • InvestorsHub NewsWire • 06/14/2023 12:55:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM